These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1399946)

  • 1. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
    Fremaux A; Sissia G; Cohen R; Geslin P
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A; Lion C; Mory F; Weber M
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
    Fremaux A; Sissia G; Geslin P
    Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
    Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
    Pechère JC
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
    Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
    Bouanchaud DH
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():95-9. PubMed ID: 1399956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.
    Johnson CC; Slavoski L; Schwartz M; May P; Pitsakis PG; Shur AL; Levison ME
    Diagn Microbiol Infect Dis; 1995 Mar; 21(3):169-73. PubMed ID: 7648837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
    Dubois J; Joly JR
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.
    Barry AL; Fuchs PC
    Antimicrob Agents Chemother; 1995 Jan; 39(1):238-40. PubMed ID: 7695313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
    Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of pristinamycin against Streptococcus pneumoniae].
    Maugein J; Rakoto-Alson O; Fourche J; Launay C;
    Pathol Biol (Paris); 2001 Sep; 49(7):583-6. PubMed ID: 11642023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections.
    Ortega M; Marco F; Almela M; Puig J; Soriano A; Mensa J
    Int J Antimicrob Agents; 2004 Dec; 24(6):616-8. PubMed ID: 15555888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The phenotype and genotype patterns of erythromycin-resistant Streptococcus pneumoniae].
    Zhao TM; Liu YN
    Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):329-32. PubMed ID: 15182500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
    Hoban DJ; Weshnoweski B; Palatnick L; Zhanel CG; Davidson RJ
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():59-65. PubMed ID: 1399952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.